Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
103.80B
Market cap103.80B
Price-Earnings ratio
37.08
Price-Earnings ratio37.08
Dividend yield
Dividend yield
Average volume
14.22M
Average volume14.22M
High today
$71.76
High today$71.76
Low today
$69.78
Low today$69.78
Open price
$71.47
Open price$71.47
Volume
14.27M
Volume14.27M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$69.52
52 Week low$69.52

Stock Snapshot

Boston Scientific(BSX) stock is priced at $70.00, giving the company a market capitalization of 103.8B. It carries a P/E multiple of 37.08.

As of 2026-03-11, Boston Scientific(BSX) stock has fluctuated between $69.78 and $71.76. The current price stands at $70.00, placing the stock +0.3% above today's low and -2.5% off the high.

Boston Scientific(BSX) shares are trading with a volume of 14.27M, against a daily average of 14.22M.

During the past year, Boston Scientific(BSX) stock moved between $69.52 at its lowest and $109.50 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $69.52 at its lowest and $109.50 at its peak.

BSX News

TipRanks 15h
Boston Scientific Targets Drug-Resistant Motor Epilepsy With New Deep Brain Stimulation Trial

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific (BSX) is backing a pilot trial called “Combined CM and STN Stimu...

TipRanks 2d
Boston Scientific: CHAMPION AF Trial Poised to Strengthen Watchman Evidence, Broaden Adoption, and Support Buy Rating

Boston Scientific, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen maintained a Buy rating on t...

Simply Wall St 3d
A Look At Boston Scientific Valuation After Class Actions And Electrophysiology Guidance Cuts

Boston Scientific (BSX) is under pressure after a series of securities class actions and investigations tied to its U.S. electrophysiology segment, where underp...

A Look At Boston Scientific Valuation After Class Actions And Electrophysiology Guidance Cuts

Analyst ratings

97%

of 38 ratings
Buy
97.4%
Hold
2.6%
Sell
0%

More BSX News

Simply Wall St 4d
Boston Scientific Recall And Lawsuits Weigh On Outlook And Valuation Gap

Boston Scientific’s AXIOS Stent and Delivery Systems are under a Class I recall following reports of serious injuries and fatalities. The recall has coincided...

Boston Scientific Recall And Lawsuits Weigh On Outlook And Valuation Gap
TipRanks 5d
Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific Corp. is launching the ENTRUST registry, a real-world study of i...

Nasdaq 5d
BSX July 17th Options Begin Trading

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the July 17th expiration. One of the key data points that goes into...

BSX July 17th Options Begin Trading
Simply Wall St 5d
How Investors Are Reacting To Boston Scientific Expanding Credit Line And Farapulse Indication

On February 26, 2026, Boston Scientific entered into a new US$3.00 billion revolving credit agreement maturing in 2031, adding flexible funding capacity governe...

How Investors Are Reacting To Boston Scientific Expanding Credit Line And Farapulse Indication
Simply Wall St 6d
Is There Now An Opportunity In Boston Scientific After Recent Share Price Pullback

If you are wondering whether Boston Scientific is priced attractively or already reflects most of its potential, you are in the right place for a value focused...

Is There Now An Opportunity In Boston Scientific After Recent Share Price Pullback
TipRanks 7d
Boston Scientific: Share Price Weakness Creates Opportunity Amid Strong Growth Outlook and Margin Expansion

Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, retaining the price target of $100.00. Josh Jennings has given his Buy rating d...

TipRanks 7d
Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating

Travis Steed, an analyst from Bank of America Securities, reiterated the Buy rating on Boston Scientific. The associated price target remains the same with $105...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.